Literature DB >> 25159345

Self-expanding foam for prehospital treatment of intra-abdominal hemorrhage: 28-day survival and safety.

Adam P Rago1, Michael J Duggan, John Beagle, Miroslav P Peev, John Marini, John O Hwabejire, Patricia Hannett, Greg Zugates, Rany Busold, Marc Helmick, George Velmahos, Marc A Demoya, Daniel Dante Yeh, Peter J Fagenholz, Upma Sharma, David R King.   

Abstract

BACKGROUND: Intracavitary noncompressible hemorrhage remains a significant cause of preventable death on the battlefield and in the homeland. We previously demonstrated the hemostatic efficacy of an in situ self-expanding poly(urea)urethane foam in a severe, closed-cavity, hepatoportal exsanguination model in swine. We hypothesized that treatment with, and subsequent explantation of, foam would not adversely impact 28-day survival in swine.
METHODS: Following a closed-cavity splenic transection, animals received either fluid resuscitation alone (control group, n = 6) or resuscitation plus foam treatment at doses of 100 mL (n = 6), 120 mL (n = 6), and 150 mL (n = 2). Foam was allowed to polymerize in situ and was explanted after 3 hours. The animals were recovered and monitored for 28 days.
RESULTS: All 18 animals in the 100-mL, 120-mL, and control groups survived to the 28-day endpoint without complications. The 150-mL group was terminated after the acute phase (n = 2). En bloc explantation of the foam took less than 2 minutes and was associated with millimeter-sized remnant particles. All foam animals required some level of enteric repair (imbrication or resection). Excluding the aborted 150-mL group, all animals survived, with no differences in renal or hepatic function, serum chemistries, or semiquantitative abdominal adhesion scores. Histologic analysis demonstrated that remnant particles were associated with a fibrotic capsule and mild inflammation, similar to that of standard suture reaction. In addition, safety testing (including genotoxicity, pyrogenicity, and cytotoxicity) was performed consistent with the ISO-10993 standard, and the materials passed all tests.
CONCLUSION: For a distinct dose range, 28-day recovery after foam treatment and explantation for noncompressible, intra-abdominal hemorrhage is not associated with significant physiologic or biochemical evidence of end-organ dysfunction. A foam volume exceeding the maximum tolerable dose was identified. Bowel repair is required to ensure survival.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25159345     DOI: 10.1097/TA.0000000000000380

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  5 in total

1.  Comparative Evaluation of Biological Performance, Biosecurity, and Availability of Cellulose-Based Absorbable Hemostats.

Authors:  Yadong Wu; Fang Wang; Yudong Huang
Journal:  Clin Appl Thromb Hemost       Date:  2018-01-24       Impact factor: 2.389

Review 2.  A review of two emerging technologies for pre-hospital treatment of non-compressible abdominal hemorrhage.

Authors:  Brendan M McCracken; Kevin R Ward; Mohamad Hakam Tiba
Journal:  Transfusion       Date:  2022-06-24       Impact factor: 3.337

Review 3.  Prehospital control of life-threatening truncal and junctional haemorrhage is the ultimate challenge in optimizing trauma care; a review of treatment options and their applicability in the civilian trauma setting.

Authors:  S E van Oostendorp; E C T H Tan; L M G Geeraedts
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-09-13       Impact factor: 2.953

Review 4.  Hemostatic agents for prehospital hemorrhage control: a narrative review.

Authors:  Henry T Peng
Journal:  Mil Med Res       Date:  2020-03-25

5.  Novel use of XSTAT 30 for mitigation of lethal non-compressible torso hemorrhage in swine.

Authors:  Alicia M Bonanno; Todd L Graham; Lauren N Wilson; James D Ross
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.